OCTANT Funding & Investors
Emeryville, CA
Octant, Inc. operates as a biotechnology company. The Company develops a multiplexed technology that uses synthetic biology, genome engineering, next-generation sequencing, and computational tools to measure the activity of receptor pathways in human cells. Octant serves customers in the United States.
https://www.octant.bio/Total Amount Raised: $115,000,000
OCTANT Funding Rounds
Series B
$80,000,000
Series B Investors
Catalio Capital ManagementFifty YearsAndreessen HorowitzBristol-Myers SquibbAllen & CompanyWhat If VenturesFlucas VenturesBiovergeSeries A
$30,000,000
Series A Investors
Andreessen Horowitz8 | partnersSV AngelAllen & CompanySujay JaswaFifty YearsLing WongSeed
$5,000,000
Seed Investors
Lux CapitalRefactor CapitalSV AngelUlu VenturesKatie HaunLars Fjeldsoe-NielsenFour Cities Capital
Funding info provided by Diffbot.